Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -209.46%-31.9M | ---- | 519.96%29.15M | ---- | 78.27%-6.94M | ---- | 74.24%-31.93M | ---- | -16.57%-123.95M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -3.84%-1.11M | ---- | -346.44%-1.07M | ---- | 74.52%-239K | ---- | 68.90%-938K | ---- | 4.28%-3.02M |
| Interest expense - adjustment | ---- | -74.39%1.39M | ---- | -12.36%5.44M | ---- | -26.61%6.2M | ---- | -37.92%8.45M | ---- | -39.79%13.61M |
| Impairment and provisions: | ---- | -63.15%-2.09M | ---- | -108.34%-1.28M | ---- | -47.39%15.36M | ---- | -47.31%29.2M | ---- | 37.16%55.41M |
| -Impairment of property, plant and equipment (reversal) | ---- | 10.00%352K | ---- | --320K | ---- | ---- | ---- | -12.09%5.34M | ---- | -51.55%6.08M |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | --14.56M | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | -52.53%-2.44M | ---- | -300.63%-1.6M | ---- | -96.65%798K | ---- | -51.65%23.85M | ---- | 77.12%49.33M |
| Asset sale loss (gain): | ---- | ---1.54M | ---- | ---- | ---- | 68.54%-13.09M | ---- | -1,603.29%-41.6M | ---- | --2.77M |
| -Loss (gain) from sale of subsidiary company | ---- | ---1.47M | ---- | ---- | ---- | 68.54%-13.09M | ---- | -3,780.22%-41.6M | ---- | ---1.07M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---65K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.84M |
| Depreciation and amortization: | ---- | -40.94%31.27M | ---- | -6.81%52.95M | ---- | -33.40%56.82M | ---- | -24.96%85.32M | ---- | -25.63%113.69M |
| Exchange Loss (gain) | ---- | 0.00%-1K | ---- | 97.62%-1K | ---- | 71.43%-42K | ---- | ---147K | ---- | ---- |
| Special items | ---- | 111.60%906K | ---- | 12.67%-7.81M | ---- | -32.66%-8.94M | ---- | 82.94%-6.74M | ---- | -28,122.86%-39.51M |
| Operating profit before the change of operating capital | ---- | -103.97%-3.07M | ---- | 57.48%77.37M | ---- | 18.07%49.13M | ---- | 118.94%41.61M | ---- | -82.12%19M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -155.61%-213K | ---- | -25.63%383K | ---- | -79.92%515K | ---- | 124.02%2.57M | ---- | 148.93%1.15M |
| Accounts receivable (increase)decrease | ---- | 11,782.11%14.62M | ---- | -96.24%123K | ---- | -83.00%3.27M | ---- | 250.05%19.23M | ---- | 867.25%5.49M |
| Accounts payable increase (decrease) | ---- | -82.34%2.43M | ---- | 35.78%13.75M | ---- | 204.29%10.12M | ---- | -660.13%-9.71M | ---- | 105.27%1.73M |
| Special items for working capital changes | ---- | 52.11%-6.43M | ---- | -167.60%-13.43M | ---- | 69.81%-5.02M | ---- | -2,284.49%-16.62M | ---- | -91.72%761K |
| Cash from business operations | 132.27%24.13M | -90.63%7.33M | -72.02%10.39M | 34.77%78.19M | 58.91%37.12M | 56.49%58.02M | -28.92%23.36M | 31.76%37.07M | 143.12%32.87M | -65.17%28.14M |
| Other taxs | ---- | ---- | ---- | -92.50%140K | -50.29%87K | 109.19%1.87M | -75.25%175K | -79.13%892K | 123.93%707K | 126.94%4.28M |
| Net cash from operations | 132.27%24.13M | -90.64%7.33M | -72.08%10.39M | 30.81%78.33M | 58.10%37.21M | 57.73%59.88M | -29.90%23.54M | 17.13%37.96M | 217.83%33.57M | -50.07%32.41M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | --3K | -46.64%842K | ---- | 156.59%1.58M | 1,527.66%765K | 30,650.00%615K | --47K | -99.74%2K | ---- | -25.93%760K |
| Decrease in deposits (increase) | ---- | 200.00%2M | 300.00%4M | -110.00%-2M | 71.42%-2M | 200.00%20M | ---7M | -200.01%-20M | ---- | 200.00%20M |
| Sale of fixed assets | ---- | --1.44M | --1.44M | ---- | ---- | ---- | ---- | ---- | 157.50%5.15M | --2.87M |
| Purchase of fixed assets | ---892K | 13.32%-1.39M | ---- | 38.41%-1.6M | -12.84%-1.6M | 18.90%-2.6M | 30.30%-1.42M | 73.42%-3.2M | 54.46%-2.03M | 72.45%-12.04M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---61K |
| Sale of subsidiaries | ---- | ---112K | ---- | ---- | ---- | ---124K | ---- | ---- | ---- | --750K |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | --66K | ---- | ---- | ---- | ---13M |
| Net cash from investment operations | -116.35%-889K | 237.65%2.78M | 291.88%5.44M | -111.25%-2.02M | 66.13%-2.83M | 177.42%17.96M | -368.46%-8.37M | -3,113.43%-23.2M | -82.61%3.12M | 98.85%-722K |
| Net cash before financing | 46.84%23.24M | -86.75%10.11M | -53.96%15.83M | -1.97%76.31M | 126.64%34.37M | 427.29%77.84M | -58.66%15.17M | -53.41%14.76M | 28.81%36.69M | 1,320.39%31.69M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | ---- | -66.29%3.37M | -75.00%10M | --10M | --40M |
| Refund | ---- | 37.00%-14.45M | ---- | -224.57%-22.93M | -4.79%-3.64M | 76.05%-7.07M | 43.82%-3.47M | -41.67%-29.51M | 27.97%-6.18M | -66.35%-20.83M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --37.5M |
| Interest paid - financing | 84.01%-243K | 44.10%-725K | 45.64%-1.52M | -1.81%-1.3M | 8.24%-2.8M | 20.82%-1.27M | 31.14%-3.05M | -85.37%-1.61M | 42.35%-4.43M | 96.16%-868K |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---750K |
| Net cash from financing operations | 46.47%-15.86M | 33.64%-63.66M | 23.35%-29.62M | -54.05%-95.92M | 7.08%-38.65M | 24.14%-62.27M | -23.95%-41.59M | -2,468.34%-82.08M | 24.34%-33.56M | 97.46%-3.2M |
| Effect of rate | ---- | ---- | ---- | 160.00%104K | ---- | --40K | ---- | ---- | ---- | -102.17%-4K |
| Net Cash | 153.51%7.38M | -173.02%-53.55M | -222.86%-13.8M | -225.90%-19.61M | 83.83%-4.27M | 123.14%15.58M | -943.44%-26.43M | -336.27%-67.32M | 119.75%3.13M | 123.03%28.49M |
| Begining period cash | -70.19%22.74M | -20.36%76.29M | -20.36%76.29M | 19.48%95.8M | 19.48%95.8M | -45.64%80.18M | -45.64%80.18M | 23.94%147.5M | 23.94%147.5M | -50.94%119.01M |
| Cash at the end | -51.79%30.13M | -70.19%22.74M | -31.72%62.49M | -20.36%76.29M | 70.26%91.52M | 19.48%95.8M | -64.31%53.76M | -45.64%80.18M | 46.03%150.63M | 23.94%147.5M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | -- | -- | -- | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | ShinWing Certified Public Accountants (Hong Kong) Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.